Adam D. Levy

Insider Reports History

Location
Watertown, MA
Signature
/s/ Adam D. Levy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adam D. Levy:

Company Role Class Num Shares Value Price $ Report Date Ownership
Acrivon Therapeutics, Inc. Chief Financial Officer Common Stock 20,983 $35,635 $1.70 14 Jan 2026 Direct
Acrivon Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 132,925 01 Mar 2026 Direct

Insider Reports Filed by Adam D. Levy

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRV Acrivon Therapeutics, Inc. 01 Mar 2026 1 $0 4 Chief Financial Officer 03 Mar 2026, 16:19
ACRV Acrivon Therapeutics, Inc. 14 Jan 2026 1 +$14,999 4 Chief Financial Officer 16 Jan 2026, 16:01
ACRV Acrivon Therapeutics, Inc. 01 Aug 2025 1 -$1,467 4 Chief Financial Officer 05 Aug 2025, 16:59
ACRV Acrivon Therapeutics, Inc. 01 Apr 2025 1 $0 4 Chief Financial Officer 03 Apr 2025, 16:30
ACRV Acrivon Therapeutics, Inc. 01 Apr 2025 0 $0 3 Chief Financial Officer 03 Apr 2025, 16:28